These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27341599)

  • 1. Chemotherapy Maintenance.
    Kasi PM; Grothey A
    Cancer J; 2016; 22(3):199-204. PubMed ID: 27341599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial.
    Hegewisch-Becker S; Graeven U; Lerchenmüller CA; Killing B; Depenbusch R; Steffens CC; Al-Batran SE; Lange T; Dietrich G; Stoehlmacher J; Tannapfel A; Reinacher-Schick A; Quidde J; Trarbach T; Hinke A; Schmoll HJ; Arnold D
    Lancet Oncol; 2015 Oct; 16(13):1355-69. PubMed ID: 26361971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group.
    Simkens LH; van Tinteren H; May A; ten Tije AJ; Creemers GJ; Loosveld OJ; de Jongh FE; Erdkamp FL; Erjavec Z; van der Torren AM; Tol J; Braun HJ; Nieboer P; van der Hoeven JJ; Haasjes JG; Jansen RL; Wals J; Cats A; Derleyn VA; Honkoop AH; Mol L; Punt CJ; Koopman M
    Lancet; 2015 May; 385(9980):1843-52. PubMed ID: 25862517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The continuum of care: a paradigm for the management of metastatic colorectal cancer.
    Goldberg RM; Rothenberg ML; Van Cutsem E; Benson AB; Blanke CD; Diasio RB; Grothey A; Lenz HJ; Meropol NJ; Ramanathan RK; Becerra CH; Wickham R; Armstrong D; Viele C
    Oncologist; 2007 Jan; 12(1):38-50. PubMed ID: 17227899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab.
    Roohullah A; Wong HL; Sjoquist KM; Gibbs P; Field K; Tran B; Shapiro J; Mckendrick J; Yip D; Nott L; Gebski V; Ng W; Chua W; Price T; Tebbutt N; Chantrill L
    World J Gastroenterol; 2015 May; 21(17):5352-8. PubMed ID: 25954110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic therapy for metastatic colorectal cancer: current options, current evidence.
    Kelly H; Goldberg RM
    J Clin Oncol; 2005 Jul; 23(20):4553-60. PubMed ID: 16002847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
    Pentheroudakis G; Fountzilas G; Kalofonos HP; Golfinopoulos V; Aravantinos G; Bafaloukos D; Papakostas P; Pectasides D; Christodoulou C; Syrigos K; Economopoulos T; Pavlidis N;
    Crit Rev Oncol Hematol; 2008 Jun; 66(3):237-47. PubMed ID: 18243010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Maintenance therapy for colorectal cancer].
    Yamaguchi S; Kato S
    Gan To Kagaku Ryoho; 2014 Aug; 41(8):932-6. PubMed ID: 25132024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study protocol of the TRICOLORE trial: a randomized phase III study of oxaliplatin-based chemotherapy versus combination chemotherapy with S-1, irinotecan, and bevacizumab as first-line therapy for metastatic colorectal cancer.
    Komatsu Y; Ishioka C; Shimada K; Yamada Y; Gamoh M; Sato A; Yamaguchi T; Yuki S; Morita S; Takahashi S; Goto R; Kurihara M
    BMC Cancer; 2015 Sep; 15():626. PubMed ID: 26353772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimum use of biologics and role of maintenance therapy in colon cancer.
    Marshall J
    Semin Oncol; 2006 Dec; 33(6 Suppl 11):S33-5. PubMed ID: 17178283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance therapy in metastatic colorectal cancer.
    Marshall JL
    Clin Adv Hematol Oncol; 2014 Jun; 12(6):388-90. PubMed ID: 25003569
    [No Abstract]   [Full Text] [Related]  

  • 12. Outcome of first line systemic treatment in elderly compared to younger patients with metastatic colorectal cancer: a retrospective analysis of the CAIRO and CAIRO2 studies of the Dutch Colorectal Cancer Group (DCCG).
    Venderbosch S; Doornebal J; Teerenstra S; Lemmens W; Punt CJ; Koopman M
    Acta Oncol; 2012 Sep; 51(7):831-9. PubMed ID: 22794910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progress in adjuvant and palliative chemotherapy of colorectal cancer: current status and perspectives].
    Scheithauer W
    Wien Klin Wochenschr; 1993; 105(20):568-79. PubMed ID: 7505075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance Therapy in Colorectal Cancer: Moving the Artillery Down While Keeping an Eye on the Enemy.
    Aprile G; Giuliani F; Lutrino SE; Fontanella C; Bonotto M; Rihawi K; Fasola G
    Clin Colorectal Cancer; 2016 Mar; 15(1):7-15. PubMed ID: 26421728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Options for Second-Line Treatment in Metastatic Colorectal Cancer.
    Lee JJ; Sun W
    Clin Adv Hematol Oncol; 2016 Jan; 14(1):46-54. PubMed ID: 27057668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy of metastatic colorectal cancer.
    Prescrire Int; 2010 Oct; 19(109):219-24. PubMed ID: 21180382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconsidering the benefit of intermittent versus continuous treatment in the maintenance treatment setting of metastatic colorectal cancer.
    Sunakawa Y; Bekaii-Saab T; Stintzing S
    Cancer Treat Rev; 2016 Apr; 45():97-104. PubMed ID: 27002945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives on the role of sequential or combination chemotherapy for first-line and salvage therapy in advanced colorectal cancer.
    Hobday TJ; Goldberg RM
    Clin Colorectal Cancer; 2002 Nov; 2(3):161-9. PubMed ID: 12482332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innovations in chemotherapy for metastatic colorectal cancer: an update of recent clinical trials.
    O'Neil BH; Goldberg RM
    Oncologist; 2008 Oct; 13(10):1074-83. PubMed ID: 18922828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming the challenges of primary tumor management in patients with metastatic colorectal cancer unresectable for cure and an asymptomatic primary tumor.
    Matsumoto T; Hasegawa S; Matsumoto S; Horimatsu T; Okoshi K; Yamada M; Kawada K; Sakai Y
    Dis Colon Rectum; 2014 Jun; 57(6):679-86. PubMed ID: 24807591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.